Author:
Vrdoljak Ana Lucić,Berend Suzana,Želježić Davor,Piljac-Žegarac Jasenka,Pleština Stjepko,Kuča Kamil,Radić Božica,Mladinić Marin,Kopjar Nevenka
Subject
Pharmacology,Toxicology,General Medicine
Reference37 articles.
1. New approaches to prevent intestinal toxicity of irinotecan-based regimens;Alimonti;Cancer Treat Rev,2004
2. CPT-11-induced cholinergic effects in cancer patients (letter);Gandia;J Clin Oncol,1993
3. Phase I and pharmacological study of the novel topoisomerase I inhibitor 7-ethyl-10-[4-(1-piperidino)-1-piperidino]-carbonyloxycamptothecin (CPT-11) administered as a ninety-minute infusion every 3 weeks;Rowinsky;Cancer Res,1994
4. Bradycardia induced by irinotecan: a case report;Miya;Japan J Clin Oncol,1998
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献